Trash or Treasure: Extracellular microRNAs and cell-to-cell communication

Frontiers in Genetics

Volumn 4, Issue SEP, 2013, Pages

  Kosaka, Nobuyoshi ^a   Yoshioka, Yusuke ^a   Hagiwara, Keitaro ^a   Tominaga, Naoomi ^a   Katsuda, Takeshi ^a   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cell to cell communication; Circulating microRNA; Exosomes; Extracellular microRNA; Extracellular vesicles; Secretory microRNA

Indexed keywords

EID: 84886040203     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00173     Document Type: Review

References (77)

1. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U.S.A. 108, 5003-5008. doi:10.1073/pnas.1019055108.
2. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136. doi:10.1038/sj.onc.1210856.
3. Bobrie, A., Colombo, M., Raposo, G., and Théry, C. (2011). Exosome secretion:molecular mechanisms and roles in immune responses. Traffic 12, 1659-1668. doi:10.1111/j.1600-0854.2011.01225.x.
4. Camps, C., Buffa, F. M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., et al. (2008). hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14, 1340-1348. doi:10.1158/1078-0432.CCR-07-1755.
5. Cantaluppi, V., Biancone, L., Figliolini, F., Beltramo, S., Medica, D., Deregibus, M. C., et al. (2012a). Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant. 21, 1305-1320. doi:10.3727/096368911X627534.
6. Cantaluppi, V., Gatti, S., Medica, D., Figliolini, F., Bruno, S., Deregibus, M. C., et al. (2012b). Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412-427. doi:10.1038/ki.2012.105.
7. Chan, Y. C., Banerjee, J., Choi, S. Y., and Sen, C. K. (2012). miR-210:the master hypoxamir. Microcirculation 19, 215-223. doi:10.1111/j.1549-8719.2011.00154.x.
8. Chim, S. S., Shing, T. K., Hung, E. C., Leung, T. Y., Lau, T. K., Chiu, R. W., et al. (2008). Detection and characterization of placental microRNAs in maternal plasma. Clin. Chem. 54, 482-490. doi:10.1373/clinchem.2007.097972.
9. Crosby, M. E., Kulshreshtha, R., Ivan, M., and Glazer, P. M. (2009). MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69, 1221-1229. doi:10.1158/0008-5472.CAN-08-2516.
10. Dickinson, B. A., Semus, H. M., Montgomery, R. L., Stack, C., Latimer, P. A., Lewton, S. M., et al. (2013). Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur. J. Heart Fail. 15, 650-659. doi:10.1093/eurjhf/hft018.
11. Ebert, M. S., and Sharp, P. A. (2012). Roles for microRNAs in conferring robustness to biological processes. Cell 149, 515-524. doi:10.1016/j.cell.2012.04.005.
12. Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., et al. (2008). MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883. doi:10.1074/jbc. M800731200.
13. Fayyad-Kazan, H., Bitar, N., Najar, M., Lewalle, P., Fayyad-Kazan, M., Badran, R., et al. (2013). Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J. Transl. Med. 11, 31. doi:10.1186/1479-5876-11-31.
14. Fleischhacker, M., and Schmidt, B. (2007). Circulating nucleic acids (CNAs) and cancer-a survey. Biochim. Biophys. Acta 1775, 181-232.
15. Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D. W., Kaper, F., et al. (2012). Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra68. doi:10.1126/scitranslmed.3003726.
16. Forte, E., and Luftig, M. A. (2011). The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect. 13, 1156-1167. doi:10.1016/j.micinf.2011.07.007.
17. Gibbings, D. J., Ciaudo, C., Erhardt, M., and Voinnet, O. (2009). Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143-1149. doi:10.1038/ncb1929.
18. Gourzones, C., Gelin, A., Bombik, I., Klibi, J., Verillaud, B., Guigay, J., et al. (2010). Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol. J. 7, 271. doi:10.1186/1743-422X-7-271.
19. Hsu, C. M., Lin, P. M., Wang, Y. M., Chen, Z. J., Lin, S. F., and Yang, M. Y. (2012). Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol. 33, 1933-1942. doi:10.1007/s13277-012-0454-8.
20. Huang, X., Ding, L., Bennewith, K. L., Tong, R. T., Welford, S. M., Ang, K. K., et al. (2009). Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35, 856-867. doi:10.1016/j.molcel.2009.09.006.
21. Ismail, N., Wang, Y., Dakhlallah, D., Moldovan, L., Agarwal, K., Batte, K., et al. (2013). Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood 121, 984-995. doi:10.1182/blood-2011-08-374793.
22. Javillier, M., and Fabrykant, M. (1931). Recherches experimentales sur le phosphore sanguin et particulièrement sur variations de la phosphatemie. Bull. Soc. Chim. Biol. 13, 1253. Jung, E. J., Santarpia, L., Kim, J., Esteva, F. J., Moretti, E., Buzdar, A. U., et al. (2012). Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients. Cancer 118, 2603-2614. doi:10.1002/cncr.26565.
23. Kamm, R. C., and Smith, A. G. (1972). Nucleic acid concentrations in normal human plasma. Clin. Chem. 18, 519-522.
24. Kanaan, Z., Rai, S. N., Eichenberger, M. R., Roberts, H., Keskey, B., Pan, J., et al. (2012). Plasma miR-21:a potential diagnostic marker of colorectal cancer. Ann. Surg. 256, 544-551. doi:10.1097/SLA.0b013e318265bd6f.
25. Kim, V. N., Han, J., and Siomi, M. C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139. doi:10.1038/nrm2632.
26. Kogure, T., Lin, W. L., Yan, I. K., Braconi, C., and Patel, T. (2011). Intercellular nanovesicle-mediated microRNA transfer:a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 54, 1237-1248. doi:10.1002/hep.24504.
27. Komatsu, S., Ichikawa, D., Takeshita, H., Konishi, H., Nagata, H., Hirajima, S., et al. (2012). Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin. Biol. Ther. 12(Suppl. 1), S53-S59. doi:10.1517/14712598.2012.681373.
28. Kosaka, N., Iguchi, H., Hagiwara, K., Yoshioka, Y., Takeshita, F., and Ochiya, T. (2013). Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem. 288, 10849-10859. doi:10.1074/jbc. M112.446831.
29. Kosaka, N., Iguchi, H., and Ochiya, T. (2010a). Circulating microRNA in body fluid:a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 101, 2087-2092. doi:10.1111/j.1349-7006.2010.01650.x.
30. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., and Ochiya, T. (2010b). Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452. doi:10.1074/jbc. M110.107821.
31. Kosaka, N., Sugiura, K., Yamamoto, Y., Yoshioka, Y., Miyazaki, H., Komatsu, N., et al. (2008). Identification of erythropoietin-induced microRNAs in haematopoietic cells during erythroid differentiation. Br. J. Haematol. 142, 293-300. doi:10.1111/j.1365-2141.2008.07151.x.
32. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., and Semenza, G. L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis:novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004. doi:10.1128/MCB.21.12.3995-4004.2001.
33. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., et al. (2008). Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675. doi:10.1111/j.1365-2141.2008.07077.x.
34. Li, B. S., Zhao, Y. L., Guo, G., Li, W., Zhu, E. D., Luo, X., et al. (2012). Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS ONE 7:e41629. doi:10.1371/journal.pone.0041629.
35. Li, J., Zhang, Y., Liu, Y., Dai, X., Li, W., Cai, X., et al. (2013). Microvesicle-mediated transfer of miR-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem. 288, 23586-23596. doi:10.1074/jbc. M113.489302.
36. Lianidou, E. S., and Markou, A. (2011). Circulating tumor cells in breast cancer:detection systems, molecular characterization, and future challenges. Clin. Chem. 57, 1242-1255. doi:10.1373/clinchem.2011.165068.
37. Lo, A. K., Dawson, C. W., Jin, D. Y., and Lo, K. W. (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J. Pathol. 227, 392-403. doi:10.1002/path.4025.
38. Luo, Y., Wang, C., Chen, X., Zhong, T., Cai, X., Chen, S., et al. (2013). Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome. Clin. Chem. 59, 658-666. doi:10.1373/clinchem.2012.195297.
39. Madhavan, D., Zucknick, M., Wallwiener, M., Cuk, K., Modugno, C., Scharpff, M., et al. (2012). Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin. Cancer Res. 18, 5972-5982. doi:10.1158/1078-0432.CCR-12-1407.
40. Mandel, P., and Metais, P. (1947). Les acides nucleiques du plasma sanguin chez l'homme. C. R. Acad. Sci. Paris 142, 241-243. Medina, P. P., Nolde, M., and Slack, F. J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90. doi:10.1038/nature09284.
41. Mendell, J. T., and Olson, E. N. (2012). MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187. doi:10.1016/j.cell.2012.02.005.
42. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., and Patel, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658. doi:10.1053/j.gastro.2007.05.022.
43. Mocharla, P., Briand, S., Giannotti, G., Dörries, C., Jakob, P., Paneni, F., et al. (2013). AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs:role for proangiogenic effects and alterations in type 2 diabetics. Blood 121, 226-236. doi:10.1182/blood-2012-01-407106.
44. Murakami, Y., Toyoda, H., Tanahashi, T., Tanaka, J., Kumada, T., Yoshioka, Y., et al. (2012). Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PLoS ONE 7:e48366. doi:10.1371/journal.pone.0048366.
45. Murtaza, M., Dawson, S. J., Tsui, D. W., Gale, D., Forshew, T., Piskorz, A. M., et al. (2013). Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108-112. doi:10.1038/nature12065.
46. Niu, Z., Goodyear, S. M., Rao, S., Wu, X., Tobias, J. W., Avarbock, M. R., et al. (2011). MicroRNA-21 regulates the self-renewal of mouse spermatogonial stem cells. Proc. Natl. Acad. Sci. U.S.A. 108, 12740-12745. doi:10.1073/pnas.1109987108.
47. Okuhara, A., Nakasa, T., Shibuya, H., Niimoto, T., Adachi, N., Deie, M., et al. (2012). Changes in microRNA expression in peripheral mononuclear cells according to the progression of osteoarthritis. Mod. Rheumatol. 22, 446-457. doi:10.1007/s10165-011-0536-2.
48. Ouyang, L., Liu, P., Yang, S., Ye, S., Xu, W., and Liu, X. (2013). A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med. Oncol. 30, 340. doi:10.1007/s12032-012-0340-7.
49. Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A., Hopmans, E. S., Lindenberg, J. L., et al. (2010). Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. U.S.A. 107, 6328-6333. doi:10.1073/pnas.0914843107.
50. Ranghino, A., Cantaluppi, V., Grange, C., Vitillo, L., Fop, F., Biancone, L., et al. (2012). Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int. J. Immunopathol. Pharmacol. 25, 75-85.
51. Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles:exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383. doi:10.1083/jcb.201211138.
52. Reddi, K. K., and Holland, J. F. (1976). Elevated serum ribonuclease in patients with pancreatic cancer. Proc. Natl. Acad. Sci. U.S.A. 73, 2308-2310. doi:10.1073/pnas.73.7.2308.
53. Roderburg, C., Luedde, M., Vargas Cardenas, D., Vucur, M., Scholten, D., Frey, N., et al. (2013). Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis. PLoS ONE 8:e54612. doi:10.1371/journal.pone.0054612.
54. Sanfiorenzo, C., Ilie, M. I., Belaid, A., Barlési, F., Mouroux, J., Marquette, C. H., et al. (2013). Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS ONE 8:e54596. doi:10.1371/journal.pone.0054596.
55. Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., et al. (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425-436. doi:10.1001/jama.299.4.425.
56. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476. doi:10.1038/ncb1800.
57. Tomasetti, M., Staffolani, S., Nocchi, L., Neuzil, J., Strafella, E., Manzella, N., et al. (2012). Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients. Clin. Biochem. 45, 575-581. doi:10.1016/j.clinbiochem.2012.02.009.
58. Turchinovich, A., and Burwinkel, B. (2012). Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol. 9, 1066-1075. doi:10.4161/rna.21083.
59. Turchinovich, A., Weiz, L., Langheinz, A., and Burwinkel, B. (2011). Characterization of extracellular circulating microRNA. Nucleic Acids Res. 39, 7223-7233. doi:10.1093/nar/gkr254.
60. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi:10.1038/ncb1596.
61. Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., and Remaley, A. T. (2011). MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 13, 423-433. doi:10.1038/ncb2210.
62. Wagner, J., Riwanto, M., Besler, C., Knau, A., Fichtlscherer, S., Röxe, T., et al. (2013). Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 33, 1392-1400. doi:10.1161/ATVBAHA.112.300741.
63. Wang, F., Zheng, Z., Guo, J., and Ding, X. (2010). Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol. Oncol. 119, 586-593. doi:10.1016/j.ygyno.2010.07.021.
64. Wang, H., Peng, W., Ouyang, X., Li, W., and Dai, Y. (2012a). Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 160, 198-206. doi:10.1016/j.trsl.2012.04.002.
65. Wang, H. J., Zhang, P. J., Chen, W. J., Feng, D., Jia, Y. H., and Xie, L. X. (2012b). Four serum microRNAs identified as diagnostic biomarkers of sepsis. J. Trauma Acute Care Surg. 73, 850-854. doi:10.1097/TA.0b013e31825a7560.
66. Watson, J. D., and Crick, F. H. (1953). Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171, 737-738. doi:10.1038/171737a0.
67. Wong, A. M., Kong, K. L., Tsang, J. W., Kwong, D. L., and Guan, X. Y. (2012). Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118, 698-710. doi:10.1002/cncr.26309.
68. Wynn, T. A., Chawla, A., and Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496, 445-455. doi:10.1038/nature12034.
69. Yamamoto, Y., Ibusuki, M., Okumura, Y., Kawasoe, T., Kai, K., Iyama, K., et al. (2008). Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res. Treat. 110, 465-475. doi:10.1007/s10549-007-9742-1.
70. Yaman Agaoglu, F., Kovancilar, M., Dizdar, Y., Darendeliler, E., Holdenrieder, S., Dalay, N., et al. (2011). Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol. 32, 583-588. doi:10.1007/s13277-011-0154-9.
71. Yao, B., La, L. B., Chen, Y. C., Chang, L. J., and Chan, E. K. (2012). Defining a new role of GW182 in maintaining miRNA stability. EMBO Rep. 13, 1102-1108. doi:10.1038/embor.2012.160.
72. Yoshioka, Y., Kosaka, N., Ochiya, T., and Kato, T. (2012). Micromanaging iron homeostasis:hypoxia-inducible micro-RNA-210 suppresses iron homeostasis-related proteins. J. Biol. Chem. 287, 34110-34119. doi:10.1074/jbc. M112.356717.
73. Yu, C. H., Xu, C. F., and Li, Y. M. (2009). Association of MicroRNA-223 expression with hepatic ischemia/reperfusion injury in mice. Dig. Dis. Sci. 54, 2362-2366. doi:10.1007/s10620-008-0629-8.
74. Zeng, X., Xiang, J., Wu, M., Xiong, W., Tang, H., Deng, M., et al. (2012). Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS ONE 7:e46367. doi:10.1371/journal.pone.0046367.
75. Zernecke, A., Bidzhekov, K., Noels, H., Shagdarsuren, E., Gan, L., Denecke, B., et al. (2009). Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci. Signal. 2, ra81. doi:10.1126/scisignal.2000610.
76. Zhang, Y., Liu, D., Chen, X., Li, J., Li, L., Bian, Z., et al. (2010). Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133-144. doi:10.1016/j.molcel.2010.06.010.
77. Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., et al. (2011). Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J. Clin. Oncol. 29, 4781-4788. doi:10.1200/JCO.2011.38.2697.